Amino Medical Science
Amino Medical Science is pioneering the next generation of therapeutics by leveraging advanced stable isotope tracer methodology and kinetic modeling to develop targeted medical products. Their approach focuses on restoring normal metabolic fluxes through disease-affected pathways, aiming to improve safety and efficacy in medicine delivery. The company specializes in small molecule therapies across various therapeutic areas including heart failure, cachexia, obesity, fatty liver disease, and failure to thrive, with a commitment to developing treatments that enhance quality of life, longevity, and disease recovery.
Industries
Nr. of Employees
small (1-50)
Products
Clinical development programs targeting metabolic diseases
Pipeline-stage therapeutic programs (small molecule) focused on treating heart failure, cachexia, obesity, fatty liver disease, and failure to thrive using a metabolism-focused approach.
Clinical development programs targeting metabolic diseases
Pipeline-stage therapeutic programs (small molecule) focused on treating heart failure, cachexia, obesity, fatty liver disease, and failure to thrive using a metabolism-focused approach.
Services
Therapeutic development using quantitative human biology
End-to-end development of small molecule therapeutics combining stable isotope tracer studies, kinetic modeling, and substrate strategies to restore metabolic flux.
Therapeutic development using quantitative human biology
End-to-end development of small molecule therapeutics combining stable isotope tracer studies, kinetic modeling, and substrate strategies to restore metabolic flux.
Expertise Areas
- Small molecule therapeutics
- Metabolic pathway-targeted drug development
- Quantitative human metabolic studies
- Kinetic and predictive clinical modeling
Key Technologies
- Stable isotope tracer methodology
- Metabolic flux analysis
- Kinetic modeling
- Predictive algorithmic modeling